Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EDOXABAN vs RIVAROXABAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EDOXABAN vs RIVAROXABAN: Safety Overview

Metric EDOXABAN RIVAROXABAN
Total FAERS Reports 8,334 131,274
Deaths Reported 992 19,233
Death Rate 11.9% 14.7%
Hospitalizations 4,729 70,513
Average Patient Age 77.2 yrs 70.0 yrs
% Female Patients 46.5% 47.7%
FDA Approval Date Jan 8, 2015 Apr 10, 2025
Manufacturer Daiichi Sankyo Inc. Macleods Pharmaceuticals Limited
Route ORAL ORAL
Marketing Status Prescription Prescription